4.8 Article

Nonsteroidal Anti-Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus

期刊

GASTROENTEROLOGY
卷 141, 期 6, 页码 2000-2008

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2011.08.036

关键词

Gastroesophageal Reflux Disease; Chemoprevention; Cancer Risk; Tumor

向作者/读者索取更多资源

BACKGROUND & AIMS: The incidence of Barrett's esophagus and esophageal adenocarcinoma has increased despite surveillance of patients with Barrett's esophagus. Limited data indicate that nonsteroidal anti-inflammatory drug (NSAID) and statin use reduce the risk for esophageal adenocarcinoma. We investigated whether NSAID or statin use reduces the risk of neoplastic progression from Barrett's esophagus. METHODS: We performed a prospective study of 570 patients with Barrett's esophagus at 3 academic and 12 regional Dutch hospitals. Information on medication use was collected in patient interviews at each surveillance visit and cross-checked with pharmacy records. Patients completed a questionnaire about use of over-the-counter medication. Incident cases of high-grade dysplasia and adenocarcinoma were identified during the follow-up period. RESULTS: During a median follow-up period of 4.5 years, 38 patients (7%) developed high-grade dysplasia or adenocarcinoma. After Barrett's esophagus had been diagnosed, 318 patients (56%) used NSAIDs for a median duration of 2 months, 161 (28%) used aspirin for a median duration of 5 years, 209 (37%) used statins for a median duration of 5 years, and 107 (19%) used NSAIDs and statins. NSAID and statin use were each associated with a reduced risk of neoplastic progression (hazard ratio [HR], 0.47; P = .030 and HR, 0.46; P = .048, respectively). Use of a combination of NSAIDs and statins increased the protective effect (HR, 0.22; P = .028). CONCLUSIONS: NSAID and statin use reduce the risk of neoplastic progression in patients with Barrett's esophagus. Use of a combination of NSAIDs and statins appears to have an additive protective effect.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model

Reinier G. S. Meester, Hilliene J. van de Schootbrugge-vandermeer, Emilie C. H. Breekveldt, Lucie de Jonge, Esther Toes-Zoutendijk, Arthur Kooyker, Daan Nieboer, Christian R. Ramakers, Manon C. W. Spaander, Anneke J. van Vuuren, Ernst J. Kuipers, Folkert J. van Kemenade, Iris D. Nagtegaal, Evelien Dekker, Monique E. van Leerdam, Iris Lansdorp-Vogelaar

Summary: The prognostic potential of repeated faecal haemoglobin (F-Hb) concentration measurements in faecal immunochemical test (FIT)-based screening for colorectal cancer (CRC) was examined. The study found that F-Hb concentrations in rounds 1 and 2 were the strongest predictors. In external validation, the model retained similar discrimination accuracy. This suggests that individuals can be accurately identified as low or high risk based on age, sex, and prior F-Hb concentrations, and risk stratification should be considered based on this information.
Article Gastroenterology & Hepatology

Advanced serrated polyps as a target of screening: detection rate and positive predictive value within a fecal immunochemical test-based colorectal cancer screening population

David E. F. W. M. van Toledo, Emilie C. H. Breekveldt, Joep E. G. IJspeert, Anneke J. van Vuuren, Folkert J. van Kemenade, Christian Ramakers, Iris D. Nagtegaal, Monique E. van Leerdam, Manon C. W. Spaander, Iris Lansdorp-Vogelaar, Esther Toes-Zoutendijk, Evelien Dekker

Summary: This study assessed the detection rate and positive predictive value (PPV) of advanced serrated polyps (ASPs) in a FIT-based screening program. The results showed that 5.9% of FIT-positive screenees had ASPs, and including ASPs slightly increased the yield of the screening.

ENDOSCOPY (2023)

Article Oncology

Advanced-stage CRC incidence patterns following the phased implementation of the CRC screening programme in the Netherlands

Emilie C. H. Breekveldt, Esther Toes-Zoutendijk, Manon C. W. Spaander, Hilliene J. van de Schootbrugge-Vandermeer, Anneke J. van Vuuren, Folkert J. van Kemenade, Christian R. B. Ramakers, Evelien Dekker, Iris D. Nagtegaal, Monique E. van Leerdam, Iris Lansdorp-Vogelaar

Summary: The Dutch colorectal cancer (CRC) screening programme based on faecal immunochemical testing has shown a decrease in advanced-stage CRC incidence after its introduction in 2014. The incidence initially increased before screening but later decreased and remained below expected levels. These findings provide evidence for the effectiveness of the Dutch screening programme in reducing advanced-stage CRC incidence.

EUROPEAN JOURNAL OF CANCER (2023)

Article Surgery

Recall bias in pain scores evaluating abdominal wall and groin pain surgery

W. A. R. Zwaans, J. A. de Bruijn, J. P. Dieleman, E. W. Steyerberg, M. R. M. Scheltinga, R. M. H. Roumen

Summary: The purpose of this study was to examine whether patients tend to overestimate or underestimate their pre-operative pain levels when recalling them in the post-operative phase. The study found that a significant percentage of patients experienced recall bias, leading to misclassification of treatment outcomes.

HERNIA (2023)

Article Oncology

Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort

Delal Akdeniz, Iris Kramer, Carolien H. M. van Deurzen, Bernadette A. M. Heemskerk-Gerritsen, Michael Schaapveld, Pieter J. Westenend, Adri C. Voogd, Agnes Jager, Ewout W. Steyerberg, Stefan Sleijfer, Marjanka K. Schmidt, Maartje J. Hooning

Summary: Lobular and lobular mixed primary breast cancer histology are associated with modestly increased risk of contralateral breast cancer (CBC), and personalized risk assessment needs to consider the histology of the primary cancer as well as the impact of systemic therapy.

CANCER MEDICINE (2023)

Article Multidisciplinary Sciences

Clinical relevance of timing of assessment of ICU mortality in patients with moderate-to-severe Acute Respiratory Distress Syndrome

Jesus Villar, Jesus M. Gonzalez-Martin, Jose M. Anon, Carlos Ferrando, Juan A. Soler, Fernando Mosteiro, Juan M. Mora-Ordonez, Alfonso Ambros, Lorena Fernandez, Raquel Montiel, Anxela Vidal, Tomas Munoz, Lina Perez-Mendez, Pedro Rodriguez-Suarez, Cristina Fernandez, Rosa L. L. Fernandez, Tamas Szakmany, Karen E. A. Burns, Ewout W. Steyerberg, Arthur S. Slutsky

Summary: Mortality assessment in clinical studies of acute respiratory distress syndrome (ARDS) has not been well-defined. This study aimed to determine the timing of mortality assessment in ICU patients with moderate-to-severe ARDS, and its predictive value for treatment response. Observational cohorts and a randomized trial were analyzed, and it was found that ICU mortality rates closely approximated 28-day mortality rates. ICU mortality assessment within the first week of a trial could serve as an early predictor of treatment response for moderate-to-severe ARDS patients.

SCIENTIFIC REPORTS (2023)

Article Health Care Sciences & Services

Intensive Care Unit Physicians' Perspectives on Artificial Intelligence-Based Clinical Decision Support Tools: Preimplementation Survey Study

Siri L. van der Meijden, Anne A. H. de Hond, Patrick J. Thoral, Ewout W. Steyerberg, Ilse M. J. Kant, Giovanni Cina, M. Sesmu Arbous

Summary: This study aimed to investigate physicians' perspectives and decision-making behavior before implementing an AI-CDS tool for predicting readmission and mortality risk after ICU discharge. The survey results showed that most physicians had positive attitudes towards AI and AI-CDS tools, believing that they could support their work. Physicians expressed a willingness to incorporate a discharge AI-CDS tool into their daily clinical practice and recognized its value in their workflows.

JMIR HUMAN FACTORS (2023)

Article Health Care Sciences & Services

Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approaches

Alexandros Rekkas, Peter R. Rijnbeek, David M. Kent, Ewout W. Steyerberg, David van Klaveren

Summary: This study compared easily applicable risk-based methods to find optimal prediction methods for individualized treatment effects. The linear-interaction model showed optimal or close-to-optimal performance in many simulation scenarios. The restricted cubic splines model was optimal for strong non-linear deviations when sample size was larger.

BMC MEDICAL RESEARCH METHODOLOGY (2023)

Article Medicine, General & Internal

There is no such thing as a validated prediction model

Ben Van Calster, Ewout W. W. Steyerberg, Laure Wynants, Maarten van Smeden

Summary: Clinical prediction models should be validated before implementation, as the performance of a model may vary across patient populations and measurement procedures. Validation studies should focus on understanding and quantifying heterogeneity and monitoring performance over time, to ensure that prediction models remain up-to-date and safe for clinical decision-making.

BMC MEDICINE (2023)

Article Health Care Sciences & Services

A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databases

Alexandros Rekkas, David van Klaveren, Patrick B. Ryan, Ewout W. Steyerberg, David M. Kent, Peter R. Rijnbeek

Summary: This study proposes a standardized scalable framework to extend the assessment of treatment effect heterogeneity to the observational setting. The framework consists of five steps: definition of research aim, identification of relevant databases, development of prediction model, estimation of treatment effect within risk strata, and presentation of results. It allows for the evaluation of differential treatment effects across risk strata.

NPJ DIGITAL MEDICINE (2023)

Article Health Care Sciences & Services

Perspectives on validation of clinical predictive algorithms

Anne A. H. de Hond, Vaibhavi B. B. Shah, Ilse M. J. Kant, Ben Van Calster, Ewout W. Steyerberg, Tina Hernandez-Boussard

Summary: The generalizability of predictive algorithms is crucial for their application in clinical practice. This article provides an overview of three types of generalizability, namely temporal, geographical, and domain generalizability, based on existing literature. These types of generalizability are associated with their respective goals, methodology, and stakeholders.

NPJ DIGITAL MEDICINE (2023)

Article Oncology

Liquid Biopsies for Colorectal Cancer and Advanced Adenoma Screening and Surveillance: What to Measure?

Ellis L. Eikenboom, Saskia M. Wilting, Teoman Deger, Malgorzata I. Srebniak, Monique Van Veghel-Plandsoen, Ruben G. Boers, Joachim B. Boers, Wilfred F. J. van IJcken, Joost H. Gribnau, Peggy Atmodimedjo, Hendrikus J. Dubbink, John W. M. Martens, Manon C. W. Spaander, Anja Wagner

Summary: We assessed which ctDNA assay might be most suitable for a ctDNA-based CRC screening/surveillance blood test. The results showed that cfDNA methylation profiles could discriminate all microsatellite instable advanced neoplasia, making it a particularly promising tool for Lynch syndrome surveillance. Larger studies are needed to validate these findings.

CANCERS (2023)

Article Health Care Sciences & Services

Mining the contribution of intensive care clinical course to outcome after traumatic brain injury

Shubhayu Bhattacharyay, Pier Francesco Caruso, Cecilia Akerlund, Lindsay D. Wilson, Robert K. Stevens, David W. Menon, Ewout W. Steyerberg, David Nelson, Ari Ercole, CENTER TBI Investigators Participants

Summary: Existing methods to characterise the evolving condition of traumatic brain injury (TBI) patients in the intensive care unit (ICU) do not capture the necessary context for individualising treatment. In this study, the integration of heterogenous data from medical records was used to model the individualised impact of clinical course on 6-month functional outcome. The study showed that static variables accounted for the majority of functional outcome explanation after TBI.

NPJ DIGITAL MEDICINE (2023)

Article Surgery

Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon

Maria J. Valkema, Manon C. W. Spaander, Jurjen J. Boonstra, Jolanda M. van Dieren, Wouter L. Hazen, G. Willemien Erkelens, I. Lisanne Holster, Andries van der Linden, Klaas van der Linde, Liekele E. Oostenbrug, Rutger Quispel, Erik J. Schoon, Peter D. Siersema, Michail Doukas, Ben M. Eyck, Berend J. van der Wilk, Pieter C. van der Sluis, Bas P. L. Wijnhoven, Sjoerd M. Lagarde, J. Jan B. van Lanschot

Summary: This study aimed to assess the prevalence and severity of dysphagia in patients with preserved esophagus after neoadjuvant chemoradiotherapy. The results showed that dysphagia and clinically relevant stenosis were uncommon during active surveillance.

BRITISH JOURNAL OF SURGERY (2023)

Proceedings Paper Computer Science, Interdisciplinary Applications

Identifying and Predicting Postoperative Infections Based on Readily Available Electronic Health Record Data

Siri Lise van der Meijden, Anna van Boekel, Laurens Schinkelshoek, Harry van Goor, Mark de Boer, Ewout Steyerberg, Bart Geerts, Sesmu Arbous

Summary: Currently, postoperative infections are identified through manual chart review. In this study, a validated automated labeling method based on registrations and treatments was used to develop a high-quality prediction model (AUC 0.81) for postoperative infections.

CARING IS SHARING-EXPLOITING THE VALUE IN DATA FOR HEALTH AND INNOVATION-PROCEEDINGS OF MIE 2023 (2023)

暂无数据